UroGen Pharma (URGN) Q4 2022 Earnings

16MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-1.33
-1.24
-1.16
-1.07

Details

Expected EPS
-1.07
Actual EPS
-1.22
Surprise EPS
-0.15
Surprise Percent
+14.02%

Description

UroGen Pharma (URGN) has reported earnings of -1.22 per share for Q4 2022.

0 Comments

Share your thoughts